The groundbreaking treatment of the medication represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide803376.suomiblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57881289